478 related articles for article (PubMed ID: 24334432)
1. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
[TBL] [Abstract][Full Text] [Related]
2. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
[TBL] [Abstract][Full Text] [Related]
3. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
[TBL] [Abstract][Full Text] [Related]
4. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
5. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
6. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
[TBL] [Abstract][Full Text] [Related]
7. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
[TBL] [Abstract][Full Text] [Related]
8. Annual atrial tachyarrhythmia burden determined by device interrogation in patients with cardiac implanted electronic devices is associated with a risk of ischaemic stroke independent of known risk factors.
Wang SH; Kang YC; Wang CC; Wen MS; Hung KC; Wang CY; Chen TH
Eur J Cardiothorac Surg; 2015 May; 47(5):840-6. PubMed ID: 24970573
[TBL] [Abstract][Full Text] [Related]
9. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
[TBL] [Abstract][Full Text] [Related]
10. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
11. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
[TBL] [Abstract][Full Text] [Related]
12. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
Al-Gibbawi M; Ayinde HO; Bhatia NK; El-Chami MF; Westerman SB; Leon AR; Shah AD; Patel AM; De Lurgio DB; Tompkins CM; Lloyd MS; Merchant FM; Kiani S
Heart Rhythm; 2021 Mar; 18(3):338-346. PubMed ID: 33250442
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
[TBL] [Abstract][Full Text] [Related]
14. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
Healey JS; Wong J
Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
[TBL] [Abstract][Full Text] [Related]
16. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
[TBL] [Abstract][Full Text] [Related]
17. Impact of atrial high-rate episodes on the risk of future stroke.
Nakano M; Kondo Y; Nakano M; Kajiyama T; Hayashi T; Ito R; Takahira H; Kobayashi Y
J Cardiol; 2019 Aug; 74(2):144-149. PubMed ID: 30728105
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
[TBL] [Abstract][Full Text] [Related]
19. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.
Glotzer TV; Daoud EG; Wyse DG; Singer DE; Ezekowitz MD; Hilker C; Miller C; Qi D; Ziegler PD
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):474-80. PubMed ID: 19843914
[TBL] [Abstract][Full Text] [Related]
20. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
